Skip to main content
Equibles

MORGAN STANLEY

Position in XLO — Xilio Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$545,619
+$62,103 QoQ
Shares Held
56,954
-0.9% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 26 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. XLO ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in XLO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $545,619 56,954
2026-03-31 $483,516 57,493
2025-12-31 $537,503 839,850
2025-09-30 $810,896 961,917
2025-06-30 $982,141 1,444,326
2025-03-31 $836,825 1,155,838
2024-12-31 $956,297 1,001,359
2024-09-30 $1,199,416 1,522,102
2024-06-30 $1,054,877 1,112,740
2024-03-31 $239,657 221,905
2023-12-31 $69,995 127,265
2023-09-30 $55,419 26,265
2023-06-30 $70,781 27,016
2023-03-31 $96,808 30,539
2022-12-31 $68,891 25,611
2022-09-30 $19,903 6,840
2022-06-30 $20,553 7,040
2022-03-31 $14,873 2,104
2021-12-31 $16,605 1,038